• gmp-verlag.de
  • GMP MANUAL Login
  • Shopping cart
Stay informed!

You’d like to be regularly informed on the latest developments in Good Manufacturing Practices?

 

Subscribe to our free GMP Newsletter LOGFILE!

>>> REGISTER NOW

The New USP <1231>
Water for Pharmaceutical Purposes

a detailed Overview

>>> ORDER NOW

Award for the
GMP Compliance Adviser

GMP knowledge that convinces.

Image

On 7 June 2016 Maas & Peither GMP Publishing has received a

SIPAward in the category
"Best New Success Story" and was awarded with the 3rd place.

The GMP MANUAL (now: GMP Compliance Adviser) impressed the jury with "Safe Drugs through Better GMP Understanding".


GMP Compliance Adviser

GMP in Practice: 24 chapters written by internationally renowned industry experts.

 

GMP Regulations: 8 chapters with the most important GMP guidelines and regulations.

 

Image

>>> READ MORE

TOP 5 GMP Downloads

1. Questionnaire for preparing GMP-inspections
More than 650 typical questions related to audits and inspections.


2. GDP Audit Checklist
More than 700 questions with reference to regulations.


3. GMP Fundamentals
A quick and comprehensive overview of the complex world of GMP.


4. Industry Guide to handle OOX Test Results
Every single step of the OOX process.


5. The New USP <1231>: Water for Pharmaceutical Purposes
A compact overview of the contents of the new version of USP <1231>.


>>> More Downloads

News about GMP/cGMP

2017-02-24

Training Presentation to ICH Q11 Draft Q&A

The ICH (International Council for Harmonisation) has developed a training presentation on the ICH Q11 Q&A document Selection & Justification of Starting Materials. Therein the Expert Working Group gives answers to the following questions:

 

  • Why is the Q&A document needed now?
  • What is the perceived problem?
  • What are the implications of the document?
  • What is the scope relative to the parent guideline?
  • What general principles have to be considered on Section 5.1.1 Selection of Starting Materials for Synthetic Drug Substances and Section 5.2.1 Justification of SM selection for synthetic drug substances?
  • What are the main issues that need to be resolved?
  • What are the potential benefits from further guidance?
  • What additional guidance is provided?
  • What is the current state of the document?

Click here for direct access to the PowerPoint Presentation.

Source:

ICH: Newsroom

Comments
No comment has yet been written about this news.
 
 
Literature recommendation
ICH Q8, Q9, Q10
GMP Compliance Adviser
Single User Licence (yearly subscription)